SU
Last reporting period 31 Mar, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
18.272
Exchange
XNSE - National Stock Exchange Of India
200.2 B
Last period Cash and equivalents ,INR
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Sun Pharmaceutical
Company Analysis
SUNPHARMA.NS valuation, rating, competitors, insights and company profile
Eyestock Rating
SUNPHARMA.NS financial analysis by Eyestock methodology
Valuation
SUNPHARMA.NS valuation using historical relative method
Statements
SUNPHARMA.NS Income Statements, Balance Sheet and Cash Flow Statements
Dividends
SUNPHARMA.NS dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Sun Pharmaceutical`s Cash and equivalents for the period ended 2024-03-31 are 200.2 B INR
